The 2025 Awards will open for entries in March 2025 - more details to follow shortly.

Nominations for the 2025 TOPRA Awards for Regulatory Excellence will open in March 2025.

The Futures Award acknowledges the role of regulatory affairs scientists in realising the potential of cutting-edge technologies, such as those involving medical devices, advanced therapies and innovative medicines and their delivery systems.


Such advances help bring innovative treatments to patients faster by embracing scientific advice and combining a flexible and professional approach to certification and licensing with excellence in quality management and benefit-risk assessment. This can also include new products and innovative technologies that improve healthcare techniques and the delivery and efficacy of existing therapies.

 

This award category is open to individuals, teams or organisations.

Nominations may be for a person, team or company who has:

1. Delivered a highly innovative medical device or in vitro diagnostic medical device, new medicinal product, ATMP (advanced therapy medicinal product) or combination product.
2. Made an appreciable difference to the healthcare of patients in a therapeutic area.
3. Demonstrated clear public health benefits resulting from the new product or technology.
4. Added to the body of scientific knowledge and regulatory affairs expertise.
5. Demonstrated effective regulatory expertise in the development phase of a cutting-edge technology

 
Nominations may cover:

1. The development of a strategy or approach for handling an innovative healthcare development that may be novel or a radical development from an existing medicine or medical device/technology.
2. A piece of research that facilitates the conformity assessment or regulatory approval process of an innovative medical device or medicine.
3. A regulatory solution to a complex or innovative scientific development.

Read our Information Pack for more details about the Awards and FAQs.

Sponsored by    

Previous winners and finalists

WINNER – Orchard Therapeutics' OTL-200 Regulatory Team, UK
FINALIST – Anna Koptina Gültekin, Sweden
JOINT WINNER – Boyds Regulatory Team, UK  
JOINT WINNER – Sanofi Speciality Care Global Regulatory team, The Netherlands
FINALIST – Cherise Adair, US

WINNER – David Fairlamb, Director of Regulatory Affairs, SolasCure, UK 

WINNER – Nancy Boman, Chief Regulatory Officer, Encoded Therapeutics, USA
FINALIST - LiverSync Project Team, Norgine, UK
FINALIST - Susan Neadle, Executive Director, Amgen, USA 

WINNER - Regulatory team at Boyds, UK
FINALIST - Global Stem Cell Technology, Belgium
FINALIST - Karen Taylor and Sebastian Payne, Deloitte LLP Centre for Health Solutions, UK 

WINNER - Diamond BioPharm - UK 
FINALIST - Emilia Heimann - Immunicum AB, Sweden
FINALIST - Natasha Nesterova-Smith - Alan Boyd Consultants, UK